Recent Updates
Recently added Catalysts
NAGE Positive Sentiment

Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit

Key Takeaway: Niagen Bioscience, a leader in NAD+ research, will present at the Nasdaq X LD Micro Inaugural SF Summit on September 9, 2026. This event aims to connect 25 selected public companies with institutional investors. The presentation will showcase Niagen's commitment to healthy aging and innovation in bioscience.

Market Sentiment Analysis

POSITIVE FACTORS

  • Niagen Bioscience is recognized as a leader in NAD+ science.
  • The participation in a prestigious summit highlights the company's visibility.
  • Engagement with institutional investors may lead to new opportunities.

Full Press Release Details

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Bioscience--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the Nasdaq X LD Micro Inaugural SF Summit on Wednesday, September 9, 2026, in San Francisco, CA.Nasdaq is partnering with LD Micro to host 25 curated public companies, each delivering a 15-minute presentation to a room of institutional investors within the Nas

Frequently Asked Questions

What is the Nasdaq X LD Micro Summit?

It is an event where selected public companies present to institutional investors.

When will Niagen Bioscience present?

Niagen Bioscience will present on September 9, 2026.

What is Niagen Bioscience known for?

The company is recognized as a leader in NAD+ and healthy aging research.

How many companies will present at the summit?

A total of 25 curated public companies will present at the summit.

Last updated: Aug 26, 2026